Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Icell Gene Therapeutics LLC

Headquarters: Stony Brook, NY, United States of America
Year Founded: 2014
Status: Private

BioCentury | Nov 21, 2024
Product Development

Companies get creative with multi-targeted CARs at SITC, ASH

BioCentury’s analysis of the SITC, ASH abstracts highlights progress in bicistronic and tandem CAR Ts
BioCentury | Jun 17, 2024
Product Development

Autoimmune CAR Ts: Is CD19 enough?

Presentations from iCell, JW and others at EULAR provide new insight into autoimmune CAR T mechanisms
BioCentury | Oct 5, 2023
Product Development

Innovation in autoimmune CAR Ts doesn’t stop at CD19

Dual targeting, allogeneic designs and novel targets are all under investigation to help CAR T cells reach more autoimmune patients
BioCentury | Dec 1, 2018
Product Development

Cell therapy momentum at ASH

A survey of clinical abstracts at ASH 2018 highlights momentum in CAR Ts
BioCentury | Nov 30, 2018
Targets & Mechanisms

Souped-up CARs at ASH 2018

How modifications to CAR T and CAR NK cells stand to boost their function
Items per page:
1 - 5 of 5